IDENTIFY Kits

ID Solutions

IDENTIFY kits to detect multiple mutations in the same trial using digital PCR

IDENTIFY Kit Range

efficient, targeted, fast and reliable detection of mutations for a better patient health care management
multiplexed mutation panels for fully validated, specific and sensitive digital PCR
ready-to-use kits
quantified results
standardized validation data
for both cfDNA extracted from plasma samples and DNA extracted from FFPE tissues
CNS kits can be used on DNA extracted from FFPE tissues only

Validated on:

Length of the protocols:

Kits available:

IDEGFR, detection of EGFR mutations in non-small cell lung cancer (NSCLC)

detect and quantify activating or resistance mutations of EGFR (Epidermal Growth Factor Receptor)
three optimized kits:
SENSI-50 - activating mutations (L858R, L861Q and Del19)
RESIST-50 - mutations of resistance (T790M and C797S (cis/trans)
RARE-50 - activating mutations or rare mutations (S768I, G719X and ins20)

IDNRAS, detection of NRAS mutations from tumor DNA

IDKRAS, detection of KRAS mutations from tumor DNA

IDBRAF, detection of BRAF mutations at position V600

detection and quantification of exon 15 of the BRAF gene from DNA of tumor origin
amplification of the BRAF mutations at positions L597, A598, V600 and K601
with a distinction from the V600E mutation

IDPIK3CA, detection of PIK3CA mutations from tumor DNA

detection and quantification of mutations in the PIK3CA gene
amplification of the PIK3CA‘s mutations at E542K, E545K, Q546K, H1047R and H1047L

IDIDH1-2, detection of IDH1 and IDH2 mutations from tumor DNA

detection and quantification of mutations in the IDH1 and IDH2 genes
for genes involved in the classification of brain tumors in adults
simultaneously amplify several variants in the both region of IDH1 (R132X) and IDH2 (R172X)

IDH3F3A, detection of H3F3A mutations from tumor DNA

detection and quantification of H3F3A‘s mutations for the classification of brain tumors
amplify the H3F3A‘s mutations at positions K27M*, G34R* and G34V*

IDTERT, detection of TERT promoter mutations from tumor DNA

detection and quantification of TERT gene promoter mutations (telomere length deregulation)
amplify TERT promoter mutations at positions corresponding to the C228T and C250T mutations

IDBRAF-CNS, detection of BRAF mutations in brain tumors

detection and quantification of V600E mutation and the TKD duplication of the BRAF gene
amplify the V600E mutations (c.1799T>A) and the fusion of the KIAA1549-BRAF genes

IDFGFR1-CNS, detection of FGFR1 mutations in brain tumors

detection and quantification of recurrent mutations and tandem duplications in the TKD of FGFR1 gene
amplify the N546K and K656E mutations, exon 8 and exon 16 of the FGFR1 gene

Documents and resources

For more information visit producer's website